Dr. Jinsong Zhang explains why helping patients visualize invisible metabolic risks can drive better adherence and outcomes.
Assessing an eHealth Intervention on Quality of Life in Patients With Chronic Lymphocytic Leukemia and Myelodysplastic Syndromes: The MyPal Randomized Controlled Trial In the companion to this article ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results